CN113185553B - Chiral phosphoric acid compound with aryl indole carbazole skeleton, and preparation method and application thereof - Google Patents

Chiral phosphoric acid compound with aryl indole carbazole skeleton, and preparation method and application thereof Download PDF

Info

Publication number
CN113185553B
CN113185553B CN202110452722.0A CN202110452722A CN113185553B CN 113185553 B CN113185553 B CN 113185553B CN 202110452722 A CN202110452722 A CN 202110452722A CN 113185553 B CN113185553 B CN 113185553B
Authority
CN
China
Prior art keywords
phosphoric acid
formula
chiral
reaction
acid compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110452722.0A
Other languages
Chinese (zh)
Other versions
CN113185553A (en
Inventor
王磊
何春年
刘海涛
杨美华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110452722.0A priority Critical patent/CN113185553B/en
Publication of CN113185553A publication Critical patent/CN113185553A/en
Application granted granted Critical
Publication of CN113185553B publication Critical patent/CN113185553B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65848Cyclic amide derivatives of acids of phosphorus, in which two nitrogen atoms belong to the ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0255Phosphorus containing compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention provides a chiral phosphoric acid compound with an aryl indole carbazole skeleton, a preparation method and application thereof, wherein the chiral phosphoric acid compound has a structure shown in a formula I, the chiral phosphoric acid compound with the aryl indole carbazole skeleton can be used as a catalyst, the synthesis method is simple and efficient, the enantioselectivity is high, the yield is high, and a research foundation is provided for asymmetric synthesis of chiral organic catalysts.

Description

Chiral phosphoric acid compound with aryl indole carbazole skeleton, and preparation method and application thereof
Technical Field
The invention belongs to the technical field of compound synthesis, and relates to a chiral phosphoric acid compound with an aryl indole carbazole skeleton, and a preparation method and application thereof.
Background
Axial chiral biaryl is ubiquitous in many natural products, bioactive molecules and functional materials, and is the core structural motif of chiral catalysts and ligands that constitute asymmetric conversion reactions. So far, the asymmetric reaction promoted by the axial chiral biaryl catalyst is widely applied in the field of organic synthesis, such as chiral biaryl catalysts BINOL and H8-BINOL. Chiral Phosphoric Acid (CPA) based on BINOL bracket can effectively induce remarkable energy difference between diastereoisomer transition states in different reactions, has high-efficiency selectivity [(a)Parmar,D.;Sugiono,E.;Raja,S.;Rueping,M.Chem.Rev.2014,114,9047.(b)Shugrue,C.R.;Miller,S.J.Chem.Rev.2017,117,11894]., but the types of chiral biaryl phosphoric acid catalysts reported so far are limited. In the research of asymmetric catalysis, the design and synthesis of chiral catalysts are of great significance.
Indolocarbazoles are a very important class of high affinity ligands, which can effectively improve the corresponding induction of chiral ligands, and are key active ingredients of anticancer, antifungal, antibacterial and antihypertensive drugs. Therefore, the indolocarbazole skeleton with the advantages is introduced into chiral phosphoric acid, and the novel aryl indolocarbazole phosphoric acid catalyst developed shows better regioselectivity and stereoselectivity in the asymmetric catalysis field compared with biaryl skeleton.
In view of the foregoing, there is a need to develop chiral phosphoric acids having novel aryl indolocarbazole backbones for exploring a variety of different types of asymmetric reactions.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a chiral phosphoric acid compound with an aryl indole carbazole skeleton, and a preparation method and application thereof.
To achieve the purpose, the invention adopts the following technical scheme:
In one aspect, the present invention provides a chiral phosphoric acid compound having an aryl indole carbazole skeleton, the chiral phosphoric acid compound having a structure represented by formula I:
Wherein R 1 and R 3 are independently selected from hydrogen, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl or substituted or unsubstituted ester group, and M is R 2 and R 4 are independently selected from hydrogen, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl or substituted or unsubstituted ester group.
Preferably, the substituted or unsubstituted alkyl group is a substituted or unsubstituted alkyl group having 1 to 5 (e.g., 1,2, 3, 4, or 5) carbon atoms.
Preferably, the substituted or unsubstituted alkoxy group is a substituted or unsubstituted alkoxy group having 1 to 5 (e.g., 1, 2, 3, 4, or 5) carbon atoms.
Preferably, when the group as described above has a substituent, the substituent is halogen, an alkyl group having 1 to 5 carbon atoms, or a phenyl group.
Preferably, R 1、R2 and R 3 are independently from each other selected from hydrogen, methyl, methoxy, fluoro, chloro, bromo, benzyloxy, tert-butyl, aryl, ester or trifluoromethyl.
Preferably, the aryl group is phenyl,Wherein the wavy line represents the attachment position of the group.
Preferably, the ester group is-COOCH 3、-OC4H8CO2CH3、-COOCH2CH3 or-COOBn.
Preferably, the chiral phosphoric acid compound with aryl indole carbazole skeleton is any one of the following compounds:
In another aspect, the present invention provides a method for preparing a chiral phosphoric acid compound having an aryl indole carbazole skeleton as described above, the method comprising the steps of:
(1) The diazonium compound with M group shown in the formula II reacts with the compound shown in the formula III (indole [2,3-a ] carbazole derivative) to obtain the axial chiral aryl indole carbazole derivative shown in the formula IV, wherein the reaction formula is as follows:
(2) The axial chiral aryl indole carbazole derivative shown in the formula IV reacts with phosphorus oxychloride to obtain the chiral phosphoric acid compound shown in the formula I and having an aryl indole carbazole skeleton, wherein the reaction formula is as follows:
Preferably, the molar ratio of the diazonium compound with an M group represented by formula II to the compound of formula III in step (1) is 1:1 to 1:1.8, for example 1:1, 1:1.1, 1:1.2, 1:1.3, 1:1.4, 1:1.5, 1:1.6, 1:1.7 or 1:1.8.
Preferably, the reaction of step (1) is carried out in the presence of a catalyst, preferably tetrakis [ (S) - (+) -1-adamantyl) - (N-phthalimido) acetate ] rhodium (II) (Rh 2(S-PTAD)4).
Preferably, the catalyst is used in an amount of 0.1 to 0.8%, for example 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7% or 0.8% of the molar amount of the compound of formula III.
Preferably, the reaction of step (1) is carried out at room temperature.
Preferably, the reaction time of step (1) is 1-12 hours, for example 1 hour, 3 hours, 5 hours, 6 hours, 8 hours, 10 hours, 12 hours.
Preferably, the molar ratio of the axial chiral arylindolocarbazole derivative of formula IV to the phosphine oxide of step (2) is 1:2-1:5, e.g. 1:2, 1:2.2, 1:2.5, 1:2.8, 1:3, 1:3.5, 1:4, 1:4.5 or 1:5.
Preferably, the solvent of the reaction of step (2) is pyridine.
Preferably, the temperature of the reaction in step (2) is 50-80 ℃, e.g. 50 ℃, 55 ℃, 58 ℃, 60 ℃, 65 ℃, 68 ℃, 70 ℃, 73 ℃, 75 ℃, 78 ℃ or 80 ℃.
Preferably, the reaction time of step (2) is 1-12 hours, for example 1 hour, 3 hours, 5 hours, 6 hours, 8 hours, 10 hours, 12 hours.
The preparation method of the invention synthesizes the axial chiral aryl indolocarbazole phosphoric acid selectively through the N-H insertion reaction shaft among Rh (II) catalytic molecules, has high enantioselectivity and high yield, and provides a research basis for asymmetric synthesis of chiral organic catalysts.
In another aspect, the present invention provides the use of a chiral phosphate compound having an aryl indole carbazole skeleton as described above as a catalyst.
Preferably, the catalyst is a catalyst that catalyzes a C-C bond cross-coupling reaction of 2-naphthol and benzoquinone.
Compared with the prior art, the invention has the following beneficial effects:
the chiral phosphoric acid compound with aryl indole carbazole skeleton can be used as a catalyst, and the synthesis method is simple and efficient, high in enantioselectivity and high in yield, and provides a research foundation for asymmetric synthesis of chiral organic catalysts.
Detailed Description
The technical scheme of the invention is further described by the following specific embodiments. It will be apparent to those skilled in the art that the examples are merely to aid in understanding the invention and are not to be construed as a specific limitation thereof.
Example 1: synthesis of 3aa
Firstly, under the protection of argon, 1.0mmol of diazonaphthoquinone, 1.5mmol of indole [2,3-a ] carbazole and 1:1 molar equivalent ratio of tetrakis [ (S) - (+) -1-adamantyl) - (N-phthalimido) acetate ] rhodium (II) (Rh 2(S-PTAD)4) are mixed in chloroform, reacted for 6 hours at room temperature, concentrated to dryness under reduced pressure, and then the axial chiral arylindole carbazole derivative shown as 3aa' is obtained through column chromatography, the yield is 52%, ee 99% is obtained through HPLC analysis, the reaction formula is as follows:
secondly, under the protection of argon, 3aa' (0.5 mmol) of aryl indole carbazole derivative is added into 5ml of pyridine, then phosphorus oxychloride (2.0 mmol) is slowly added dropwise, the mixture is reacted for 7 hours at 60 ℃, cooled to room temperature, concentrated to dryness under reduced pressure, and chiral aryl indole carbazole phosphoric acid shown as 3aa is obtained through column chromatography, and the yield is 88%, ee 99% and the reaction formula is as follows:
1H NMR(600MHz,CDCl3):δ=8.28(dd,J=8.1,1.2Hz,2H),8.12–8.09(m,2H),8.05–7.95(m,4H),7.50–7.45(m,3H),7.42–7.40(m,1H),7.37–7.35(m,1H),7.23–7.21(m,1H),6.90(d,J=8.1Hz,1H),6.84(d,J=8.7Hz,1H).
13C NMR(151MHz,CDCl3):δ=143.31,143.25,141.46,141.17,133.80,133.79,132.66,132.65,130.87,130.83,130.54,130.52,130.08,130.04,129.50,129.48,129.45,127.73,127.72,127.58,127.22,126.56,126.42,126.38,125.93,125.47,124.70,124.58,121.82,121.64,121.63,120.85,120.56,118.50,118.49,118.35,113.68,113.28.
31P NMR(162MHz,CDCl3):δ=6.42。
HRMS(ESI):calcd for C28H16O3N2P[M-H]-:459.0904,found 459.0906.
Note that: the 3aa 1 H-NMR spectrum and 13 C-NMR spectrum were carried out by nuclear magnetic resonance spectroscopy (Avance II 400 MHz). 31 P NMR was performed by nuclear magnetic resonance spectroscopy (Avance II 400 MHz) and HRMS was performed by electrospray mass spectrometer (ESI) (the same applies to the examples below).
Example 2: synthesis of 3ra
Firstly, under the protection of argon, diazonaphthoquinone derivative (1.0 mmol), indole [2,3-a ] carbazole (1.5 mmol) and tetra [ (S) - (+) -1-adamantyl) - (N-phthalimido) acetate ] rhodium (II) (Rh 2(S-PTAD)4) are mixed in chloroform according to the molar equivalent ratio of 1:1.5:0.5%, after the mixture is reacted for 12 hours at room temperature, the mixture is decompressed and concentrated to dryness, and then the axial chiral arylindole carbazole derivative shown as 3ra' is obtained through column chromatography, the yield is 55%, the ee 97% is obtained through HPLC analysis, and the reaction formula is as follows:
Secondly, under the protection of argon, 3ra' (0.5 mmol) of aryl indole carbazole derivative is added into 5ml of pyridine under the protection of argon, then phosphorus oxychloride (2.0 mmol) is slowly added dropwise, the mixture is reacted for 7 hours at 60 ℃, cooled to room temperature, concentrated to dryness under reduced pressure, and chiral aryl indole carbazole phosphoric acid shown as 3ra is obtained through column chromatography, and the yield is 79%, ee 97%, and the reaction formula is as follows:
1H NMR(600MHz,CDCl3):δ=8.82(dd,J=8.3,1.1Hz,2H),8.77(d,J=8.3Hz,1H),8.31–8.29(m,2H),8.08(d,J=8.0Hz,1H),8.05(d,J=7.4Hz,1H),7.98(dd,J=8.1,1.2Hz,1H),7.93–7.87(m,2H),7.62(t,J=7.6Hz,1H),7.48–7.39(m,3H),7.33–7.29(m,1H),7.24–7.22(m,1H),6.80(d,J=8.2Hz,1H),6.66(d,J=8.4Hz,1H).
13C NMR(151MHz,CDCl3):δ=142.07,141.60,141.53,141.33,141.33,132.68,132.67,131.58,131.57,130.91,130.87,130.03,129.99,129.13,128.35,127.99,127.68,127.67,127.59,127.58,127.54,126.62,126.13,126.12,125.99,125.75,125.66,125.35,125.34,124.96,124.74,124.70,124.65,123.94,123.23,121.89,120.92,120.52,118.87,118.52,118.51,113.78,113.56.
31P NMR(162MHz,CDCl3):δ=5.24。
HRMS(ESI):calcd for C32H18O3N2P[M-H]-:509.1065,found 509.1071.
The chiral phosphoric acid 3ra is used as a novel phosphoric acid catalyst to catalyze the reaction of the compounds 4 and 5 to generate the compound 6, the catalyst dosage is 10mol% of the compound 4, the reaction solvent is DCM, the reaction is carried out for 48 hours at room temperature, and the chiral analysis of the product compound 6 proves that the chiral selectivity of the product 6 reaches 33%ee when the chiral phosphoric acid 3ra is used as the catalyst, and the chiral selectivity of the product 6 only reaches 2%ee when the chiral phosphoric acid 3ra is used as the catalyst. The indole carbazole-based phosphoric acid can be widely applied to asymmetric synthesis of different types, and better chiral control is achieved.
Commercial phosphoric acid catalysts.
The applicant states that the chiral phosphoric acid compound having an aryl indole carbazole skeleton, the preparation method and the application thereof are described by the above examples, but the present invention is not limited to the above examples, i.e. the present invention is not necessarily limited to the above examples. It should be apparent to those skilled in the art that any modification of the present invention, equivalent substitution of raw materials for the product of the present invention, addition of auxiliary components, selection of specific modes, etc., falls within the scope of the present invention and the scope of disclosure.

Claims (12)

1.A chiral phosphoric acid compound with an aryl indole carbazole skeleton, which is characterized by having a structure shown in a formula I:
Wherein R 1 and R 3 are selected from hydrogen and M is R 2 and R 4 are selected from hydrogen, and the wavy line represents the attachment site of the group.
2. The chiral phosphoric acid compound having an arylindole carbazole skeleton according to claim 1, wherein the chiral phosphoric acid compound is any one of the following compounds:
3. the method for producing a chiral phosphoric acid compound having an arylindolocarbazole skeleton according to claim 1 or 2, characterized by comprising the steps of:
(1) The diazonium compound with M group shown in the formula II reacts with the compound shown in the formula III to obtain the axial chiral aryl indole carbazole derivative shown in the formula IV, wherein the reaction formula is as follows:
The reaction in the step (1) is carried out in the presence of a catalyst, wherein the catalyst is tetra [ (S) - (+) -1-adamantyl) - (N-phthalimido) acetate ] rhodium (II);
(2) The axial chiral aryl indole carbazole derivative shown in the formula IV reacts with phosphorus oxychloride to obtain the chiral phosphoric acid compound shown in the formula I and having an aryl indole carbazole skeleton, wherein the reaction formula is as follows:
4. The process according to claim 3, wherein the molar ratio of the diazonium compound having an M group represented by formula II to the compound of formula III in step (1) is 1:1 to 1:1.8.
5. A process according to claim 3, wherein the catalyst is used in an amount of 0.1 to 0.8% of the molar amount of the compound of formula III.
6. A process according to claim 3, wherein the reaction of step (1) is carried out at room temperature.
7. A process according to claim 3, wherein the reaction time in step (1) is 1 to 12 hours.
8. The method according to claim 3, wherein the molar ratio of the axial chiral arylindolocarbazole derivative represented by formula IV in the step (2) to the phosphine oxide is 1:2 to 1:5.
9. A process according to claim 3, wherein the solvent of the reaction of step (2) is pyridine.
10. A process according to claim 3, wherein the temperature of the reaction in step (2) is 50-80 ℃.
11. A process according to claim 3, wherein the reaction time in step (2) is 1 to 12 hours.
12. Use of a chiral phosphoric acid compound having an aryl indole carbazole skeleton according to claim 1 or 2 as a catalyst;
the catalyst is a catalyst for catalyzing the cross-coupling reaction of the C-C bond of the 2-naphthol and the benzoquinone.
CN202110452722.0A 2021-04-26 2021-04-26 Chiral phosphoric acid compound with aryl indole carbazole skeleton, and preparation method and application thereof Active CN113185553B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110452722.0A CN113185553B (en) 2021-04-26 2021-04-26 Chiral phosphoric acid compound with aryl indole carbazole skeleton, and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110452722.0A CN113185553B (en) 2021-04-26 2021-04-26 Chiral phosphoric acid compound with aryl indole carbazole skeleton, and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN113185553A CN113185553A (en) 2021-07-30
CN113185553B true CN113185553B (en) 2024-07-26

Family

ID=76979274

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110452722.0A Active CN113185553B (en) 2021-04-26 2021-04-26 Chiral phosphoric acid compound with aryl indole carbazole skeleton, and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN113185553B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107501160A (en) * 2017-09-07 2017-12-22 南方科技大学 Method for synthesizing axial chiral aryl indole through organic catalysis
CN107501163A (en) * 2017-09-07 2017-12-22 南方科技大学 Method for synthesizing axial chiral aniline indole under catalysis of chiral phosphoric acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107501160A (en) * 2017-09-07 2017-12-22 南方科技大学 Method for synthesizing axial chiral aryl indole through organic catalysis
CN107501163A (en) * 2017-09-07 2017-12-22 南方科技大学 Method for synthesizing axial chiral aniline indole under catalysis of chiral phosphoric acid

Also Published As

Publication number Publication date
CN113185553A (en) 2021-07-30

Similar Documents

Publication Publication Date Title
CN110452150B (en) Axial chiral indole-naphthalene compound and preparation method thereof
Yuan et al. Organocatalytic asymmetric synthesis of arylindolyl indolin-3-ones with both axial and central chirality
CN112824422B (en) Chiral ferrocene-indole diphosphine ligand as well as preparation method and application thereof
CN114524701B (en) N-axis chiral pyrrole derivative and synthesis method thereof
CN114591344B (en) Synthesis method of chiral spiro tetrahydrofuran-pyrazolone compound
Xu et al. Palladium‐Catalyzed Atroposelective Kinetic C− H Olefination and Allylation for the Synthesis of C− B Axial Chirality
CN113549062B (en) Chiral quaternary ammonium salt phase transfer catalyst with high steric hindrance derived from cinchona alkaloid and synthesis method thereof
CN112940002B (en) Method for synthesizing octatomic bridged ring compound through palladium-catalyzed asymmetric ring addition reaction
CN113185553B (en) Chiral phosphoric acid compound with aryl indole carbazole skeleton, and preparation method and application thereof
Chen et al. A phosphine-catalysed one-pot domino sequence to access cyclopentene-fused coumarins
CN100408587C (en) Chiral phosphine thiourea compound, synthesis method and its application
CN111217809B (en) Chiral nitrogen-containing diene ligand and preparation method and application thereof
CN115536708A (en) Chiral diphosphine ligand of ferrocene skeleton and preparation method and application thereof
CN111116450B (en) Axial chiral naphthylamine squaramide organic catalyst, and preparation method and application thereof
Zhang et al. Palladium‐catalyzed Atroposelective Interannular C− H Arylation of Biaryl Aldehydes with Aryl Iodides Enabled by a Transient Directing Group Strategy
CN114478245A (en) Asymmetric synthesis method of chiral gamma-alkynyl-alpha-keto acid ester compound
CN116199713A (en) Chiral alpha-aminophosphonic acid derivative and preparation method thereof
JP2003146978A (en) METHOD FOR PRODUCING OPTICALLY ACTIVE LACTONE COMPOUND USING SALEN COBALT COMPLEX HAVING CIS-beta STRUCTURE
CN116496160B (en) Construction method of meta carbon-carbon bond of phenolic compound
CN109851598B (en) Preparation method of trifluoromethyl substituted trans enol ester
CN110194760B (en) Process for preparing 3-benzylidene-2- (7' -quinoline) -2, 3-dihydro-isoindol-1-ones
CN118056830A (en) Axis chiral indolopyrrole-furan compound and synthesis method thereof
CN117552023A (en) Preparation method of sulfur-containing cyano sulfonamide compound
CN118290432A (en) Trans-cycloolefin compound and preparation method and application thereof
Ghanem C11-Chirasil-Dex as chiral stationary phase in GC: enantioselective separation of cyclopropane derivatives

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant